PharmCADD
Combines deep learning approaches with molecular dynamics simulation and quantum calculation to create cutting-edge computational modules.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD87—131m (Dealroom.co estimates Apr 2021.)
Company register number 2848601260
Busan South Korea (HQ)
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 1.5m | 3.0m | 4.7m | 4.7m |
| % growth | - | 100 % | 57 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | Seed | |
| N/A | KRW1.0b | Series A | |
$16.0m | Series B | ||
| Total Funding | CAD23.0m | ||
Related Content
Recent News about PharmCADD
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.